Improving Patient Education for Lymphoma and Leukemia Inpatients
NCT ID: NCT02642510
Last Updated: 2017-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2014-06-30
2017-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors
NCT00945828
Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer
NCT03804164
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
NCT02129049
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
NCT01591213
St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level
NCT01185093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The experimental group will watch a DVD educational presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and patient and family members activities of importance to prevent infection and promote well-being during cancer treatment.
Participants in the control group will receive usual educational teaching by their assigned nursing staff.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DVD Structured Education
Participants in this group will watch an educational DVD in addition to standard teaching by nursing staff.
Structured Education DVD + Verbal Teaching
The structured education DVD is a 15-minute DVD presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and participant and family members activities of importance to prevent infection and promote well-being during cancer treatment.
Participants will also receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
Verbal Teaching
Participants will receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
Standard Educational Teaching
Participants in this group will receive educational teaching by their assigned nursing staff.
Verbal Teaching
Participants will receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured Education DVD + Verbal Teaching
The structured education DVD is a 15-minute DVD presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and participant and family members activities of importance to prevent infection and promote well-being during cancer treatment.
Participants will also receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
Verbal Teaching
Participants will receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to the hematology/leukemia unit (6E) at Emory University Hospital with a suspected or actual new diagnosis of leukemia or lymphoma within the past 24 hours
* English-speaking
* Completed education to at least the 6th grade level
* No significant auditory or visual deficits with corrective devices
* No central nervous system involvement of disease
* Physiologically stable
* Not at end of life
* No alterations in mental status
* Agrees to family member (family member; significant other; friend) participation in study and to selecting the individual who could participate
For Family Members:
* Willing to view DVD and read education booklet
* Selected by patient to participate
* English speaking
* No significant auditory or visual deficits with corrective devices
* No alterations in mental status
* Completed education to at least the 6th grade level
Exclusion Criteria
* Altered mental status
* Significant auditory or visual deficits with corrective devices
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christina Peters
Advanced Practitioner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Peters, NP
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University Hospital
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00073387
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.